Pain management in sickle cell disease

Pain Management Nursing

Volumn 2, Issue 4, 2001, Pages 121-131

  Jacob, Eufemia ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ANALGESICS, NON NARCOTIC; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; CODEINE; DIAZEPAM; DIPHENHYDRAMINE; HALOPERIDOL; HYDROCODONE; HYDROMORPHONE; HYDROXYZINE; IBUPROFEN; IMIPRAMINE; KETOPROFEN; KETOROLAC; LORAZEPAM; MORPHINE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORPETHIDINE; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL; PETHIDINE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ADDICTION; ADJUVANT CHEMOTHERAPY; ARTICLE; BEHAVIOR; CHRONIC PAIN; CLINICAL PRACTICE; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DOCTOR PATIENT RELATION; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; EMERGENCY HEALTH SERVICE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HOME CARE; HUMAN; INTERSTITIAL NEPHRITIS; MEDICAL SOCIETY; MEDICAL STAFF; NEUROLOGIC DISEASE; PAIN; PAIN ASSESSMENT; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SEIZURE; SICKLE CELL ANEMIA; UNITED KINGDOM; UNITED STATES; REVIEW;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; CHEMOTHERAPY, ADJUVANT; EMERGENCY SERVICE, HOSPITAL; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HOME NURSING; HUMAN; PAIN; SUBSTANCE-RELATED DISORDERS; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES;

EID: 0035543143     PISSN: 15249042     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpmn.2001.26297     Document Type: Article

References (56)

1. Serum concentration of meperidine in patients with sickle cell crises
2. Management of sickle cell disease. Non-addictive analgesics can be as effective as morphine and pethidine
3. Nonsteroidal anti-inflammatory agents: An update
4. The acute painful episode
5. Nonpharmacologic therapy of sickle cell pain
6. Pharmacology of analgesics and adjuvants
7. Neurobiology and treatment of pain
8. Sickle cell disease
9. Impact of non-narcotic oral analgesics on pain management
10. Pain and addiction
11. Guideline for the management of acute and chronic pain in sickle cell disease
12. Access to medical care for black and white Americans
13. Pain relief in sickle cell crises
14. Treatment of sickle cell anemia
15. The hospital management of patients with sickle cell disease
16. Management of patients with sickle cell disease
17. A review of evidence about factors affecting quality of pain management in sickle cell disease
18. Combination therapy with ibuprofen and methadone for chronic cancer pain
19. Evalation of fast track admission policy for children with sickle cell crises: Questionnaire survey of parents' preferences
20. Current controversies in opioid therapy
21. The treatment of cancer pain
22. Meperidine analgesia in patients with painful crisis due to sickle cell disase
23. Guidelines for the management of hospitalized narcotic addicts
24. Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates
25. Psychosocial adjustment in children and adolescents with sickle cell disease
26. Opioid analgesics and antagonists
27. Morphine for painful crises in sickle cell disese
28. White doctors and black patients: Influence of race on the doctor-patient relationship
29. The spectrum of epilepsy in sickle cell anemia
30. Pharmacology of spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and isobolographic analysis of the NSAID interaction
31. Undertreatment of medical inpatients with narcotic analgesics
32. Variability in inpatient management of sickle cell disease pain crisis
33. The tragedy of needless pain
34. Sickle cell disease: A psychosocial approach
35. Psychotropic drugs
36. Pain management in the child with sickle cell disease
37. Painful crises in sickle cell disease-patients' perspectives
38. Low frequency of meperidine-associated seizures in sickle cell disease
39. Pain management in sickle cell ddisease: Rationale and techniaues
40. Survey of pain management therapy provided for children with sickle cell disease
41. Acute chest syndrome in sickle cell disease: Etiology and clinical correlates
42. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
43. Addiction rate in patients treated with narcotics
44. The acute painful episode
45. Sickle cell-related pain: Perceptions of medical practitioners
46. Pain analgesia and addiction
47. Treatment of iatrogenic drug dependence in the general hospital
48. Nonnarcotic analgesics
49. Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses
50. Meperidine induced seizures in sickle cell patients
51. Opioid analgesics in the treatment of chronic intractable pain of neo-plastic origin
52. Prescribing narcotics to habitual and addicted narcotic users
53. Opioids
54. Multidisciplinary approach to pain management in sickle cell disease
55. Pain in children and adolescents with sickle cell disease: A descriptive study
56. Health professional perceptions of opioid dependence among patients with pain